Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer

BACKGROUND: Pretreatment serum squamous cell carcinoma antigen (SCCA) is a prognostic biomarker in women with cervical cancer. SCCA has not been evaluated as an early indicator of response to chemoradiation therapy (CRT). The molecular role of the two SCCA isoforms, SCCA1 (SERPINB3) and SCCA2 (SERPI...

Descripción completa

Detalles Bibliográficos
Autores principales: Markovina, Stephanie, Wang, Songyan, Henke, Lauren E, Luke, Cliff J, Pak, Stephen C, DeWees, Todd, Pfeifer, John D, Schwarz, Julie K, Liu, Weijun, Chen, Shuai, Mutch, David, Wang, Xiaowei, Powell, Matthew A, Siegel, Barry A, Dehdashti, Farrokh, Silverman, Gary A, Grigsby, Perry W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2018
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765231/
https://www.ncbi.nlm.nih.gov/pubmed/29112685
http://dx.doi.org/10.1038/bjc.2017.390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5765231/
https://www.ncbi.nlm.nih.gov/pubmed/29112685
http://dx.doi.org/10.1038/bjc.2017.390

Ejemplares similares